Some researchers have reported that the expression of CXCL1 and CXCL2 is correlated with tumor size, metastasis, and decreased overall survival in breast, gastric, colorectal, hepatocellular, and bladder carcinoma patients26–30. Here, CXCL1 is linked to neoplasm.